Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
05/2012
05/29/2012US8188074 Biologically active methylene blue derivatives
05/29/2012US8188032 G-CSF transferrin fusion proteins
05/29/2012US8187807 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke
05/29/2012US8187588 Mycoplasma hyopneumoniae bacterin vaccine
05/29/2012CA2687927C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
05/29/2012CA2583876C A transmucosal veterinary composition comprising detomidine
05/29/2012CA2520522C Cladribine formulations for improved oral and transmucosal delivery
05/29/2012CA2516667C Treatment using dantrolene
05/24/2012US20120129823 Contraception process and administration form for the same
05/24/2012US20120128658 Rage g82s-related methods and compositions for treating inflammatory disorders
05/24/2012US20120128627 Il-17 homologous polypeptides and therapeutic uses thereof
05/23/2012EP2455083A1 Pharmaceutical composition for dermal use comprising calcipotriol and a corticosteroid
05/23/2012EP1601374B2 Compositions and methods for diagnosing and treating an inflammation
05/23/2012CN1906162B Hydroxy piperidine derivatives to treat gaucher disease
05/22/2012US8183350 Compositions and methods for promoting neuronal outgrowth
05/22/2012US8183209 Treatment of T-cell mediated diseases
05/22/2012US8183026 Methods of preparation of live attenuated bacterial vaccine by alteration of DNA adenine methylase (Dam) activity in those bacteria
05/22/2012US8182836 Abuse-resistant oral dosage forms and method of use thereof
05/22/2012US8182816 Methods of treating cancer
05/22/2012CA2532089C Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
05/22/2012CA2492938C Cancer vaccines containing epitopes of oncofetal antigen
05/22/2012CA2440884C Transdermal patch for administering fentanyl
05/22/2012CA2250407C Linseed crush for regulating bowel activity
05/17/2012US20120122991 Method for treating cancer by increasing amp-activated kinase activity
05/17/2012US20120122967 Compositions and products containing r-equol, and methods for their making
05/17/2012US20120122804 Substituted quinobenzoxazine analogs
05/17/2012US20120122760 Novel lipids for transfection of nucleic acids
05/17/2012US20120122216 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
05/17/2012US20120121609 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
05/16/2012CN1863556B Compositions and methods for treating coagulation related disorders
05/15/2012US8178570 Tie-2 modulators and methods of use
05/15/2012US8178532 c-Met modulators and method of use
05/15/2012US8178506 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
05/15/2012US8178492 Methods and compositions for modulating adipocyte function
05/15/2012US8178308 Use of IL-27 agonists to increase interferon-gamma production
05/15/2012CA2543353C Oral drug delivery system
05/15/2012CA2542726C Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes
05/15/2012CA2526616C Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
05/15/2012CA2516581C Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination
05/15/2012CA2511849C Stable topical drug delivery compositions comprising a multilamellar liquid crystal phosphatidylcholine carrier
05/15/2012CA2505705C Compositions and methods for the diagnosis and treatment of tumor
05/15/2012CA2409286C Dog & cat food compositions having a probiotic lactobacillus strain
05/10/2012US20120115746 Compositions and methods for treating and diagnosing irritable bowel syndrome
05/10/2012US20120114741 Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
05/10/2012US20120114662 Human monoclonal antibodies against bacillus anthracis protective antigen
05/10/2012US20120114613 Definitive endoderm cell populations
05/10/2012US20120114560 Abeta binding molecules
05/10/2012US20120114547 Stabilization and ionic triggering of nitric oxide release
05/10/2012US20120111325 Low Dose Pharmaceutical Powders for Inhalation
05/09/2012EP2450043A1 Pharmaceutical composition for dermal use to treat psoriasis, sebopsoriasis or seborrhoic dermatitis comprising a vitamin D and a corticosteroid
05/09/2012EP2100605B9 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer
05/09/2012EP1660686B1 Hpv cd8+ t-cell epitopes
05/08/2012US8173786 Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
05/08/2012US8173651 Pyridine compounds
05/08/2012US8173177 Compositions of botanical extracts for cancer therapy
05/08/2012CA2589095C Protein formulation for administering an active enamel substance
05/08/2012CA2514356C Novel inhibitors of formation of advanced glycation endproducts (ages)
05/08/2012CA2353574C Analogues of glp-1
05/08/2012CA1341629C Hepatitis c diagnostics and vaccines
05/03/2012US20120108525 Methods and Compositions for the Treatment of Gastrointestinal Disorders
05/03/2012US20120107827 PSMCs As Modifiers of the RB Pathway and Methods of Use
05/03/2012US20120107303 Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
05/03/2012US20120107301 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
05/02/2012EP2446881A1 Orally Dissolving Films
05/02/2012EP1549246B1 Antibiotic micropheres for treatment of infections and osteomyelitis
05/02/2012EP1415992B1 Diamine derivatives
05/02/2012CN102432511A Facially amphiphilic polymers and oligomers and uses thereof
05/01/2012US8168663 Pharmaceutically acceptable salt of 6-carboxy-2-(3,5 dichlorophenyl)-benzoxazole, and a pharmaceutical composition comprising the salt thereof
05/01/2012US8168233 administering to a patient with pancretitis and pain associated with pancretitis, an amylin, an amylin analog such as 25, 28, 29Pro-h-amylicn or an amylin agonist, amylin agonist is not a calcitonin and an analgesic
05/01/2012US8168180 Methods and compositions for modulating angiogenesis
05/01/2012US8168175 Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
05/01/2012US8167855 Ocular drug delivery device
05/01/2012CA2516455C Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
05/01/2012CA2516093C Automated insomnia treatment system
05/01/2012CA2400559C Humanized antibodies that sequester .alpha..beta. peptide
04/2012
04/25/2012EP2444409A2 Compositions and methods for the treatment of immune related diseases
04/25/2012EP2444102A1 Combination therapy for treating protein deficiency disorders
04/25/2012EP2444069A1 Controlled release compositions
04/25/2012EP1638505B1 Amphiphilic pyridinium compounds, method of making and use thereof
04/25/2012CN1756558B Specific chaperone combination for enzyme and active parts of the enzyme
04/25/2012CN101087631B 护肤用方法和材料 Skin care methods and materials used
04/25/2012CN101069744B 流感疫苗组合物 Influenza vaccine composition
04/24/2012US8165698 Face mask
04/24/2012US8163530 Nucleic acids encoding respiratory syncytial virus subgroup B strain 9320
04/24/2012US8163494 Method for assessing metastatic properties of breast cancer
04/24/2012US8163306 Coated tablet; an active ingredient, excipient, a swellable composition and a reactive composition; a water insoluble polymer surrounding the core, and leachable component
04/24/2012CA2542834C Conjugates or co-administration of igf-1 receptor ligands with anti-cancer chemotherapeutic agents
04/24/2012CA2524054C Immunosuppressant compounds and compositions
04/24/2012CA2511843C Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
04/24/2012CA2511479C Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
04/19/2012US20120095058 Method of preventing survival of retrovirally cells and of inhibiting formation of infectious retroviruses
04/18/2012EP2441474A1 Methods and compositions for modulating adipocyte function
04/18/2012EP2441467A1 Combination therapy for treating protein deficiency disorders
04/18/2012EP2441465A1 Compositions and methods for healthy pregnancy
04/18/2012CN101579343B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/18/2012CN101177414B 抗癌化合物zd1839的新晶形、其制备方法及含该晶形的药用组合物 The new crystalline form of the anticancer compound zd1839, its preparation method and a pharmaceutical composition containing the crystalline form of
04/17/2012US8158672 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
04/17/2012US8158645 Compound, corresponding compositions, preparation and/or treatment methods
04/17/2012CA2585705C Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
04/17/2012CA2516589C Hiv replication inhibiting pyrimidines and triazines
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 295